Disability

TeachTown Announces the Launch of Language Accelerator

WOBURN, Mass., Nov. 12, 2024 /PRNewswire/ -- TeachTown, a leading provider of special education curriculum for students with disabilities, is pleased…

1 year ago

Dr. JD Dudum of Dudum Chiropractic Co-Authors Study Demonstrating the Effectiveness of His Non-Surgical Spinal Decompression Technique

The study demonstrated that nonsurgical spinal decompression improved patient-reported pain intensity, function, and quality of life, offering a viable, non-invasive…

1 year ago

The Arthritis Foundation Welcomes Zoetis as Two-Year National Presenting Sponsor of Jingle Bell Run and Walk to Cure Arthritis

The partnership joins forces to support arthritis patients and their beloved pets ATLANTA, GA / ACCESSWIRE / November 12, 2024…

1 year ago

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1

New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results also showcase the…

1 year ago

Group Health Life and Benefits Brokers can leverage PerfectQuote’s Digital Quoting Platform to receive underwritten quotes directly from Principal Financial Group®.

AUSTIN, Texas, Nov. 7, 2024 /PRNewswire/ -- PerfectQuote, Inc., a leading group health digital quoting platform, announced its collaboration with…

1 year ago

MedAllies Earns 2024 Great Place To Work Certification™

FISHKILL, N.Y., Nov. 5, 2024 /PRNewswire/ -- MedAllies is proud to be Certified™ by Great Place To Work® for the…

1 year ago

In latest interoperability expansion, Epic advances personalized care

Epic now fully supports version 3 of the United States Core Data for Interoperability standards—over a year ahead of the…

1 year ago

Homelessness is More Than Just Statistics – It’s Real People, Real Lives, and Real Struggles

HomeAid Launches Annual Homelessness Awareness Campaign for NovemberIRVINE, CA / ACCESSWIRE / October 31, 2024 / Homelessness is more than…

1 year ago

Praxis Bioresearch Obtains FDA Clearance On the IND Application for Its Lead Candidate PRX-P4-003 In Alzheimer’s Disease Apathy

LOS ANGELES, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Praxis Bioresearch reports that the United States Food and Drug Administration (FDA)…

1 year ago